Agilent Technologies Inc (A)
154.46
+0.23
(+0.15%)
USD |
NYSE |
May 20, 11:52
Agilent Technologies Accounts Receivable (Quarterly): 1.295B for Jan. 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 1.295B |
October 31, 2023 | 1.291B |
July 31, 2023 | 1.339B |
April 30, 2023 | 1.401B |
January 31, 2023 | 1.459B |
October 31, 2022 | 1.405B |
July 31, 2022 | 1.345B |
April 30, 2022 | 1.237B |
January 31, 2022 | 1.205B |
October 31, 2021 | 1.172B |
July 31, 2021 | 1.122B |
April 30, 2021 | 1.075B |
January 31, 2021 | 1.087B |
October 31, 2020 | 1.038B |
July 31, 2020 | 930.00M |
April 30, 2020 | 886.00M |
January 31, 2020 | 966.00M |
October 31, 2019 | 930.00M |
July 31, 2019 | 856.00M |
April 30, 2019 | 819.00M |
January 31, 2019 | 833.00M |
October 31, 2018 | 776.00M |
July 31, 2018 | 733.00M |
April 30, 2018 | 754.00M |
January 31, 2018 | 751.00M |
Date | Value |
---|---|
October 31, 2017 | 724.00M |
July 31, 2017 | 678.00M |
April 30, 2017 | 677.00M |
January 31, 2017 | 653.00M |
October 31, 2016 | 631.00M |
July 31, 2016 | 590.00M |
April 30, 2016 | 602.00M |
January 31, 2016 | 617.00M |
October 31, 2015 | 606.00M |
July 31, 2015 | 584.00M |
April 30, 2015 | 576.00M |
January 31, 2015 | 615.00M |
October 31, 2014 | 626.00M |
July 31, 2014 | 891.00M |
April 30, 2014 | 903.00M |
January 31, 2014 | 849.00M |
October 31, 2013 | 899.00M |
July 31, 2013 | 875.00M |
April 30, 2013 | 916.00M |
January 31, 2013 | 874.00M |
October 31, 2012 | 923.00M |
July 31, 2012 | 950.00M |
April 30, 2012 | 909.00M |
January 31, 2012 | 814.00M |
October 31, 2011 | 860.00M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
856.00M
Minimum
Jul 2019
1.459B
Maximum
Jan 2023
1.160B
Average
1.172B
Median
Oct 2021
Accounts Receivable (Quarterly) Benchmarks
Bio-Rad Laboratories Inc | 444.81M |
Revvity Inc | 588.97M |
Azenta Inc | 154.67M |
Harvard Bioscience Inc | 15.31M |
Bionano Genomics Inc | 8.313M |